From July 1, 2022 to September 30, 2022, the company has repurchased 324,735 shares, representing 0.37% for CNY 29.05 million. With this, the company has completed the repurchase of 336,548 shares, representing 0.39% for CNY 30.11 million under the buyback announced on April 1, 2022.
Qingdao NovelBeam Technology Co.,Ltd.
Equities
688677
CNE100005410
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.85 CNY | +1.76% | -5.20% | -19.50% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.50% | 713M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- 688677 Stock
- News Qingdao NovelBeam Technology Co.,Ltd.
- Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on April 1, 2022.